I agree that this site is using cookies. You can find further informations here.
X
Ranzenigo, Martina
30  results:
Search for persons X
?
1

Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infec..:

Alberton, Francesca ; Galli, Laura ; Lolatto, Riccardo...
Drug Design, Development and Therapy.  18 (2024)  - p. 1153-1163 , 2024
Link: https://doi.org/10.2147/..
 
?
2

Otitis in Patients With Community-Acquired Bacterial Mening..:

Ranzenigo, Martina ; van Soest, Thijs M ; Hensen, Erik F...
Clinical Infectious Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
3

Is shorter duration of antibiotic treatment feasible in pat..:

Ponta, Giacomo ; Ranzenigo, Martina ; Marzi, Alessandra...
International Journal of Antimicrobial Agents.  63 (2024)  2 - p. 107077 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: ..:

Canetti, Diana ; Galli, Laura ; Lolatto, Riccardo...
Drug Design, Development and Therapy.  17 (2023)  - p. 3697-3706 , 2023
Link: https://doi.org/10.2147/..
 
?
5

Persistent ocular mpox infection in an immunocompetent indi..:

Raccagni, Angelo Roberto ; Clemente, Tommaso ; Ranzenigo, Martina...
The Lancet Infectious Diseases.  23 (2023)  6 - p. 652-653 , 2023
Link: https://doi.org/10.1016/..
 
?
6

2408. Is Shorter Antibiotic Treatment Feasible in Patients ..:

Ponta, Giacomo ; Ranzenigo, Martina ; Marzi, Alessandra...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
7

Neisseria gonorrhoeae Antimicrobial Resistance: The Future ..:

Raccagni, Angelo Roberto ; Ranzenigo, Martina ; Bruzzesi, Elena...
Journal of Clinical Medicine.  12 (2023)  24 - p. 7767 , 2023
Link: https://doi.org/10.3390/..
 
?
8

Levels of Alpha-Fetoprotein and Association with Mortality ..:

Morsica, Giulia ; Galli, Laura ; Messina, Emanuela...
Journal of Oncology.  2022 (2022)  - p. 1-10 , 2022
Link: https://doi.org/10.1155/..
 
?
9

Switching from a Non-Protease Inhibitor-Based Regimen to th..:

Ranzenigo, Martina ; Gianotti, Nicola ; Galli, Laura...
Drug Design, Development and Therapy.  16 (2022)  - p. 3737-3738 , 2022
Link: https://doi.org/10.2147/..
 
?
10

Switching from a Non-Protease inhibitor-Based Regimen To th..:

Ranzenigo, Martina ; Gianotti, Nicola ; Galli, Laura...
Drug Design, Development and Therapy.  16 (2022)  - p. 1975-1982 , 2022
Link: https://doi.org/10.2147/..
 
?
11

Symptoms and signs of conjunctivitis as predictors of disea..:

Ranzenigo, Martina ; Bruzzesi, Elena ; Galli, Laura..
Journal of Ophthalmic Inflammation and Infection.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
12

Virological and Serological Discordant Profiles in COVID-19..:

Ranzenigo, Martina ; Pastori, Claudia ; Siracusano, Gabriel...
Frontiers in Immunology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
13

Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: ..:

Canetti, Diana ; Galli, Laura ; Lolatto, Riccardo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714985/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: ..:

Canetti, Diana ; Galli, Laura ; Lolatto, Riccardo...
info:eu-repo/semantics/altIdentifier/doi/10.2147/DDDT.S437043.  , 2023
Link: https://www.dovepress.co..
 
?
15

Switching from a Non-Protease Inhibitor-Based Regimen to th..:

Ranzenigo, Martina ; Gianotti, Nicola ; Galli, Laura...
info:eu-repo/semantics/altIdentifier/doi/10.2147/DDDT.S394059.  , 2022
Link: https://www.dovepress.co..
 
1-15